Florida OIR Fines PBMs $12.6 Million After Market Conduct Exams

Florida OIR Fines PBMs $12.6 Million After Market Conduct Exams

Over the last 12 months, Florida regulators’ market conduct examinations have resulted in more than $12 million in fines for 12 pharmacy benefits managers, stemming from PBMs’ pricing models, unilateral changes to pharmacy contracts and other alleged statutory violations. Most of the PBMs have accepted the Office of Insurance Regulation findings and have already taken steps to correct deficiencies. But a few are pushing back. Capital Rx, now Judi Rx and part of Judi Health, backed by a number of institutional investors, disagreed with almost all of OIR’s eight red flags raised in the Aug. 28 market conduct exam report. Examiners, for example, found that in 19% of Capital Rx contracts reviewed, the PBM did not include terms that cover network adequacy, as required by Florida statute. “Capital Rx disagreed with all of the instances contained in the finding, stating language or similar language in the contract states, ‘Members will have access to the network of retail pharmacies established and maintained by Capital Rx to deliver covered pharmaceuticals to members. Capital Rx will maintain or develop a network in sponsor’s service area(s) that meets reasonable access standards,'” the exam report reads. The exams are the result of Florida Senate Bill 1550, the Prescription Drug Reform Act, which was signed into law in 2023. The law gave OIR the authority to examine PBMs every two years. PBMs have come under increasing scrutiny across the country as pharmacists and others have decried a lack of transparency and allegedly unfair practices that have squeezed pharmacies and have resulted in higher prices for consumers. “We must demand transparency and accountability for all pharmacy benefit managers in Florida to ensure companies cannot hide revenue, retain rebates instead of passing savings to consumers or raise costs for patients who may rely heavily on critical prescriptions,” Florida Insurance Commissioner Michael Yaworsky said in a statement. “I understand that drug-pricing can be complex, but it should never be hidden for PBMs’ own financial incentives. I want to be clear to PBMs and the associations they hide behind—the laws of Florida will be adhered to, and you will be held accountable.” The PBMs that received the largest fines this year include: Employee Health Insurance Management, a privately held company: $2.4 million Scrip World, owned by CVS Health Corp.: $2.2 million Right Rx FL, a privately owned firm: $2.1 million Capital RX Inc.: $1.6 million Related: Alabama Lawmakers Set Minimum PBM Payments to Independent Pharmacies Topics Florida Was this article valuable? Thank you! Please tell us what we can do to improve this article. Thank you! % of people found this article valuable. Please tell us what you liked about it. Here are more articles you may enjoy.

Original Source

Read the full article at Insurancejournal →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.